Circulating N-terminal pro-brain natriuretic peptide and cardiac troponin T in chronic dialysis patients

Journal of the Medical Association of Thailand

Volumn 86, Issue SUPPL.1, 2003, Pages

  Leowattana, Wattana ^b   Taruangsri, Puntapong ^a   Ong Ajyooth, Leena ^a   Pokum, Sasikant ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b NONE

Author keywords

Chronic Dialysis; Chronic Renal Failure; CTnT; NT proBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; TROPONIN T; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIALYSIS; DISEASE MARKER; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; PROTEIN DETERMINATION; REFERENCE VALUE;

ADULT; AGED; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RENAL DIALYSIS; TROPONIN T;

EID: 0041344586     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Tonolo G, McMillan M, Polonia J, et al. Plasma clearance and effects of alpha-hANP infused in patients with end-stage renal failure. Am J Physiol 1988; 254: F895-9.
2. Buckley MG, Sethi D, Markandu ND, Sagnella GA, Singer DR, MacGregor GA. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci (Lond) 1992; 83: 437-44.
3. Corboy JC, Walker RJ, Simmonds MB, Wilkins GT, Richards AM, Espiner EA. Plasma natriuretic peptides and cardiac volume during acute changes in intravascular volume in haemodialysis patients. Clin Sci (Lond) 1994; 87: 679-84.
4. Chen HH, Burnett JC Jr. The natriuretic peptides in heart failure: Diagnostic and therapeutic potentials. Proc Assoc Am Physicians 1999; 111: 406-16.
5. Parfrey PS. Cardiac and cerebrovascular disease in chronic uremia. Am J Kidney Dis 1993; 21: 77-80.
6. Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995; 47:186-92.
7. Levin A, Singer J, Thompson CR, Ross H, Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: Identifying opportunities for intervention. Am J Kidney Dis 1996; 27: 347-54.
8. Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-15.
9. Mallamaci F, Zoccali C, Tripepi G, et al. Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 2001; 59: 1559-66.
10. Akiba T, Tachibana K, Togashi K, Hiroe M, Marumo F. Plasma human brain natriuretic peptide in chronic renal failure. Clin Nephrol 1995; 44 (Suppl 1): S61-4.
11. Nishikimi T, Futoo Y, Tamano K, et al. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: Influence of coronary artery disease. Am J Kidney Dis 2001; 37: 1201-8.
12. Dierkes J, Domrose U, Westphal S, et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000; 102: 1964-9.
13. Frankel WL, Herold DA, Ziegler TW, Fitzgerald RL. Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure. Am J Clin Pathol 1996; 106: 118-23.
14. Roppolo LP, Fitzgerald R, Dillow J, Ziegler T, Rice M, Maisel A. A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: A pilot study. J Am Coll Cardiol 1999; 34: 448-54.
15. Bleyer AJ, Russell GB, Satko SG. Sudden and cardiac death rates in hemodialysis patients. Kidney Int 1999; 55: 1553-9.
16. Ooi DS, Zimmerman D, Graham J, Wells GA. Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clin Chem 2001; 47: 412-7.
17. Haller C, Zehelein J, Remppis A, Muller-Bardorff M, Katus HA. Cardiac troponin T in patients with end-stage renal disease: Absence of expression in truncal skeletal muscle. Clin Chem 1998; 44: 930-8.
18. Li D, Keffer J, Corry K, Vazquez M, Jialal I. Non-specific elevation of troponin T levels in patients with chronic renal failure. Clin Biochem 1995; 28: 474-7.
19. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106: 2941-5.
20. deFilippi CR, Tocchi M, Parmar RJ, et al. Cardiac troponin T in chest pain unit patients without ischemic electrocardiographic changes: Angiographic correlates and long-term clinical outcomes. J Am Coll Cardiol 2000; 35: 1827-34.
21. Aviles RJ, Askari AT, Lindahl B, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002; 346: 2047-52.
22. Panteghini M, Cuccia C, Pagani F, Turla C, Bonetti G, Bonini E. Coronary angiographic findings in patients with clinical unstable angina according to cardiac troponin I and T concentrations in serum. Arch Pathol Lab Med 2002; 126: 448-51.
23. Ishii J, Nomura M, Okuma T, et al. Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis. Clin Chim Acta 2001; 312: 69-79.
24. Masson S, Vago T, Baldi G, et al. Comparative measurement of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin Chem Lab Med 2002; 40: 761-3.
25. Luchner A, Hengstenberg C, Lowel H, et al. N-terminal pro-brain natriuretic peptide after myocardial infarction: A marker of cardio-renal function. Hypertension 2002; 39: 99-104.
26. Latini R, Masson S, de Angelis N, Anand I. Role of brain natriuretic peptide in the diagnosis and management of heart failure: Current concepts. J Card Fail 2002; 8: 288-99.